MedPath

A clinical study to study the drug kadukkai chooranam on Neerizhivu

Phase 2
Conditions
Health Condition 1: null- Akkini Selathumam
Registration Number
CTRI/2018/03/012756
Lead Sponsor
Dr S Neelavathy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Type II diabetes mellitus

Previously diagnosed patients which are uncontrolled or poorly controlled for more than 5 years duration of the illness

If yes in any of three

FBS above 126 mg per dl and below and equal 250mg per dl or

PPBS above 200 mg per dl and below and equal 350mg per dl

HbA1c above 6.5 and below 12

Patients with diabetic neuritis complains such as pain numbness tingling sensation of the lower limb

Neuropathic pain scale is less than 4 by 10

The clinical diagnosis was confirmed by of nerve condution studies

Exclusion Criteria

B12 deficiency

Severe anaemia

Smoking or alcohol neuropathy

Presence of foot ulcer

Endocrine disorder

Myopathy

Systemic hypertension Angina and heart failure

Type I diabetes mellitus

Pregnancy

Lactating mother

Chronic kidney disease or renal failure

Chronic liver disease

Femoral nerve dysfunction

Mechanical and traumatic nerve injury

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The therapeutic efficacy of trial drug kadukkai chooranam on AKKINI SELATHUMAMTimepoint: The therapeutic efficacy of trial drug kadukkai chooranam on AKKINI SELATHUMAM
Secondary Outcome Measures
NameTimeMethod
Evaluation of Siddha diagnostic parametersTimepoint: 90 days
© Copyright 2025. All Rights Reserved by MedPath